Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study

International Journal of Infectious Diseases (2021) - Comments
pubmed: 33713817 doi: 10.1016/j.ijid.2021.03.015 issn: 1201-9712 issn: 1878-3511

Anuja Pandit, Nirav Bhalani, B.L. Shashi Bhushan, Parshottam Koradia, Shweta Gargiya, Vinay Bhomia, Kevinkumar Kansagra